These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20712600)

  • 1. At the heart of tissue: endothelin system and end-organ damage.
    Iglarz M; Clozel M
    Clin Sci (Lond); 2010 Aug; 119(11):453-63. PubMed ID: 20712600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma.
    Shiwen X; Leask A; Abraham DJ; Fonseca C
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():19-26. PubMed ID: 19335743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin as a clinical target in the treatment of systemic hypertension.
    Prasad VS; Palaniswamy C; Frishman WH
    Cardiol Rev; 2009; 17(4):181-91. PubMed ID: 19525680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endothelin and endothelin receptor antagonists in renal disease.
    Neuhofer W; Pittrow D
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence.
    Neuhofer W; Pittrow D
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():50-67. PubMed ID: 19335747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endothelin in human hypertension.
    Touyz RM; Schiffrin EL
    Can J Physiol Pharmacol; 2003 Jun; 81(6):533-41. PubMed ID: 12839265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of endothelin-1 in human hypertension.
    Shreenivas S; Oparil S
    Clin Hemorheol Microcirc; 2007; 37(1-2):157-78. PubMed ID: 17641406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin receptor antagonists in preclinical models of pulmonary hypertension.
    Pullamsetti SS; Schermuly RT
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():3-13. PubMed ID: 19335741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies.
    Davie NJ; Schermuly RT; Weissmann N; Grimminger F; Ghofrani HA
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():38-49. PubMed ID: 19335746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist.
    Iglarz M; Binkert C; Morrison K; Fischli W; Gatfield J; Treiber A; Weller T; Bolli MH; Boss C; Buchmann S; Capeleto B; Hess P; Qiu C; Clozel M
    J Pharmacol Exp Ther; 2008 Dec; 327(3):736-45. PubMed ID: 18780830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin receptor antagonists.
    Motte S; McEntee K; Naeije R
    Pharmacol Ther; 2006 Jun; 110(3):386-414. PubMed ID: 16219361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition?
    Jacobs A; Preston IR; Gomberg-Maitland M
    Curr Med Res Opin; 2006 Dec; 22(12):2567-74. PubMed ID: 17166339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristic of the endogenous peptides--endothelins and their role in the connective tissue fibrosis].
    Garncarczyk A; Jurzak M; Gojniczek K
    Wiad Lek; 2008; 61(4-6):126-34. PubMed ID: 18939363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endothelin in cardiovascular disease.
    Agapitov AV; Haynes WG
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):1-15. PubMed ID: 11984741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin--role in vascular disease.
    Abraham D; Dashwood M
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v23-4. PubMed ID: 18784133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endothelins in chronic cardiac insufficiency].
    Pousset F
    Arch Mal Coeur Vaiss; 1998 Dec; 91(12 Suppl):23-6. PubMed ID: 9891817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathophysiology of endothelin in complications after solid organ transplantation: a potential novel therapeutic role for endothelin receptor antagonists.
    Raina A; Horn ET; Benza RL
    Transplantation; 2012 Nov; 94(9):885-93. PubMed ID: 23037008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin antagonism suppresses plasma and cardiac endothelin-1 levels in SHRSPs at the typical hypertensive stage.
    Jesmin S; Zaedi S; Maeda S; Togashi H; Yamaguchi I; Goto K; Miyauchi T
    Exp Biol Med (Maywood); 2006 Jun; 231(6):919-24. PubMed ID: 16741024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 in chronic renal failure and hypertension.
    Larivière R; Lebel M
    Can J Physiol Pharmacol; 2003 Jun; 81(6):607-21. PubMed ID: 12839272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 in congenital heart disease.
    Beghetti M; Black SM; Fineman JR
    Pediatr Res; 2005 May; 57(5 Pt 2):16R-20R. PubMed ID: 15817494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.